We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Beyond Coronary Thrombolysis

Richard C. Becker, MD; Joseph S. Alpert, MD
Arch Intern Med. 1988;148(7):1503-1507. doi:10.1001/archinte.1988.00380070021006.
Text Size: A A A
Published online


Coronary heart disease, the leading cause of death in the United States, is responsible for 500 000 deaths annually. Furthermore, 5 to 6 million individuals in this country suffer from symptomatic coronary disease, with the potential to sustain an acute myocardial infarction (AMI). Pump failure is the most common cause of death following AMI and is determined by the extent of myocardial necrosis. Therefore, methods to limit infarct size have been vigorously sought.

The pathogenesis of AMI in general and the contributory role of intracoronary thrombosis in particular have been debated for decades. However, the work of DeWood et al,1 performing coronary angiography during the early stages of AMI, has established an occlusive thrombus as the primary event in transmural myocardial infarction. Having recognized this important fact, attention quickly turned to interventional therapies designed to remove intracoronary thrombus, thereby restoring myocardial blood flow.2,3 Early investigations utilizing clot lysing


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

7 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.